Ping An Global Voyager Fund invests in Airdoc

Ping An Insurance Company of China’s corporate venture fund is investing in AI medical solution company Airdoc, the company announced on Saturday, Jan. 12.

"This is an important investment for Ping An and the Global Voyager Fund. Airdoc brings world class AI-driven medical imaging analytical capabilities in multiple domain areas,” Jonathan Larsen, chief innovation officer of Ping An Group and chairman and chief executive officer of the Ping An Global Voyager Fund, said in a prepared statement. “There are many applications for their solutions within the Ping An health and financial services ecosystem, in China, regionally and internationally."

Based in Beijing, Airdoc is a medical technology company that focuses on using AI to improve the efficiency of medical services. The company develops deep-learning techniques based on massive data and provides intelligent services to assist doctors and help patients.

The Ping An Global Voyager Fund, along with CITIC Group Corporation, is leading the AI medical company’s Series B investment round, according to Crunchbase. Though the company did not disclose how much the fund is investing into the AI company, it did say the fund typically seeks to invest between $10 million and $100 million in companies.

"We are excited to partner with Airdoc and proud to co-lead the firm's Series B+ round,” Marco Huesch, PhD, managing director and chief medical officer of the Ping An Global Voyager Fund, said in statement. “Airdoc's market leading medical AI retinal imaging technology offers consumers a fast, convenient and accurate screening service for more than two dozen important diseases, all available at multiple, retail check-up center locations in China.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”